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Impetigo
Impetigo is the most common bacterial infection of the skin, 
and is usually seen in children. Almost always, it is caused 
by Staphylococcus aureus or streptococci, or a combination 
of the two.1 The source of these infections is mainly nasal or 
perianal colonisation, and infection is acquired by skin-to-
skin contact, or from contact with nasal carriers. 
There are two types of impetigo:
• Impetigo contagiosa, which presents as crusted lesions 
and characteristic honey-coloured exudates. The most 
affected area is the face, especially around the nose and 
mouth (see Figure 1).
• Bullous impetigo is usually caused by Staphylococcus 
aureus. It presents with blisters that contain a turbid 
fluid. These blisters rupture and leave a “collarette” of 
scale surrounding the blister roof at the periphery of the 
ruptured lesions (see Figure 2). Some lesions may enlarge 
to form polycyclic patterns (see Figure 3).2 They occur 
anywhere, and may be widely and irregularly distributed. 
Mild and localised disease can be treated with either 
mupirocin ointment or fucidic acid ointment. Mupirocin is 
highly bactericidal to all common, primary skin pathogens. It 
induces a rapid bacteriological and clinical response that is 
equal to, or surpasses that of other topical and oral agents. 
The clinical efficacy of mupirocin has been proven in a large 
number of studies,3 and in particular, in the management of 
impetigo and furunculosis. 
Systemic antibiotics such as cloxacillin are reserved to 
treat severe disease. Mupirocin nasal ointment can be 
used to eradicate persistent nasal carriage. Vancomycin, 
clindamycin and linezolid are used for cases of methicillin-
resistant Staphylococcus aureus. 
Ecthyma
Ecthyma is a pyogenic infection of the skin. It is characterised 
by the formation of adherent crusts, beneath which ulceration 
occurs. The aetiology is similar to that of impetigo. Some 
cases are caused by Streptococcus pyogenes, some by 
S. aureus, and others by both. This means that the infection 
may be synergistic.4 Ecthyma occurs in both children and 
adults. Predisposing factors are poor hygiene, malnutrition, 
immunosuppression and skin trauma.
Lesions start as pustules, or small blisters, on an 
erythematous base. These rupture to form hard crusts of 
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Figure 1: Impetigo contagiosa in a child
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dried exudate. The crusts fall off, leaving purulent irregular 
ulcers (see Figure 4). Commonly affected areas are the 
buttocks, thighs and legs, but the ulcers may appear 
anywhere on the body.
To treat ecthyma, the underlying predisposing factor 
needs to be addressed, and antibiotics such as cloxacillin 
prescribed against both S. aureus and S. pyogenes. Topical 
therapy with mupirocin ointment should also be given.
Ecthyma gangrenosum is a rare variant, usually associated 
with Pseudomonas infection.5 It usually occurs in 
neutropenic, or immunocompromised patients with Pseudo-
monas septicaemia.5,6 There are reports of organisms other 
than Pseudomonas causing ecthyma gangrenosum.5,6 
A typical ecthyma gangrenosum lesion is a bulla which 
ruptures, leaving a deep ulcer with a necrotic base and well 
demarcated edges. It typically heals with scarring.
Management of ecthyma gangrenosum involves identi-
fication of any underlying immune deficiency, debridement, 
and the administration of intravenous antibiotics. Current 
recommendations advocate the use of aminoglycosides like 
amikacin or gentamycin, and anti-pseudomonal β-lactam 
agents such as piperacillin (or tazocin) and ceftazidime.6 
Quinolones (i.e. ciprofloxacin) also have anti-pseudomonal 
properties.
Erysipelas
Erysipelas is a bacterial infection of the dermis and upper 
subcutaneous tissue. It presents with a well-defined, raised 
edge, an indication of more superficial dermal involvement. 
Erysipelas is usually a streptococcal disease. S. aureus is 
occasionally isolated from lesions of erysipelas.4
Clinically, erysipelas present as an erythematous swelling 
with a raised, well-defined edge. In severe cases, blistering 
can occur. Erysipelas starts abruptly with acute systemic 
symptoms that may become severe with fever. The legs are 
the most commonly affected site, and an obvious wound 
can usually be identified as a possible site of inoculation. 
Erysipelas affects the face too, but here, the traumatic site 
of entry is generally not easily identifiable. Specimens for 
bacteriological examination should be collected from blister 
fluid or ulcerated surfaces. Blood cultures should also be 
taken.
In mild cases, oral monotherapy with cloxacillin is usually 
adequate, as it is bactericidal to both streptococci 
and staphylococci.4 Clarythromycin may be given in 
penicillin-allergic patients. For severe cases with possible 
complications, intravenous treatment with benzylpenicillin 
is indicated.
Cellulitis
Cellulitis is an acute, subacute or chronic inflammation 
of loose connective tissue, but generally the term applies 
to the inflammation of subcutaneous tissue in which an 
infective, generally bacterial cause is proven or assumed.4 
The causative organism is S. aureus either alone, or in 
combination with streptococci. Haemophilus influenzae 
type b is an important cause of facial cellulitis in young 
children up to the age of two years, but rarely causes 
cellulitis in adults.7
Other bacteria are occasionally implicated in cellulitis in 
specific immunosuppression or exposure settings. These 
include S. pneumoniae (the sinuses), Aeromonas hydrophila 
(complicates injuries that have been contaminated by 
soil), Pasturella multocida (inoculated by animal bites) and 
Pseudomonas aeruginosa (causing gangrenous cellulitis 
and ecthyma gangrenosum).8
Cellulitis may be caused by Acinetobacter calcoaceticus 
and S. epidermis, as well as Bacteroides fragilis and Yersinia 
anterocolitica.9 A case of anaerobic cellulitis produced 
Figure 2: Bullous impetigo. Note the “collarette” scale at the 
periphery of the lesion
Figure 3: Bullous impetigo. Note the polycyclic pattern
Figure 4: Ecthyma in a child. Note the purulent irregular ulcers
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by a clindamycin-resistant Clostridium perfringens 
has also been reported.10 Cellulitis can occur following 
infection of a surgical wound, ulceration or traumatic skin 
injury. Other predisposing factors are diabetes mellitus, 
immunosuppression, and venous or lymphatic insufficiency. 
Clinically, cellulitis presents as an erythematous swelling with 
diffuse poorly demarcated edges (see Figure 5), as opposed 
to erysipelas which has well-defined edges. Severe cellulitis 
may blister and progress to dermal necrosis. Lymphangitis 
and lymphadenopathy can result, while fever and malaise 
occur frequently. Periorbital cellulitis is particularly common 
in children. It usually follows trauma to the eyelids, which 
are then infected by streptococci or staphylococci. 
A clinical assessment should guide empiric treatment as to 
the likely pathogenic organism. If monotherapy is required, 
oral cloxacillin is sufficient. Clarythromycin can be given 
to penicillin-sensitive patients. Initial treatment must cover 
both streptococci and staphylococci. H. influenzae should 
be borne in mind when treating facial infections in young 
children. Severe cases will require intravenous treatment 
with cloxacillin or benzylpenicillin. 
Since the aetiology of cellulitis is broad, and in case an 
unusual organism is implicated, active attempts to identify 
the causative organism are necessary. Treatment should 
be given for five to ten days, but for longer periods if there 
are complications such as fasciitis, myositis, subcutaneous 
abscesses and septicaemia. In recurrent cases, long-term 
penicillin can be given orally to prevent attacks.
Recurrent episodes of cellulitis have been associated with 
post-cellulitic oedema. Oedema is a risk factor for recurrent 
disease.
Furuncles and carbuncles
A furuncle is a hair follicle abscess, resulting from infection 
with S. aureus. In contrast to superficial Staphylococcal 
folliculitis, furuncles are deep-seated. They are rare in 
childhood, but common in adults. The infecting strain of 
S. aureus is usually present in the nostrils or the perineum. 
This implies that repeated and heavy inoculation of chronic 
carriers may result in the development of furunculosis.4 
Furunculosis is common in the HIV setting.
A furuncle starts as a small follicular inflammation, later 
becoming an abscess, which then ruptures and heals, 
leaving permanent scars. Lesions can be single or multiple, 
and tend to appear in crops (see Figure 6). Fever and 
constitutional symptoms may be present. Cheek lesions 
can develop into cavernous sinus thrombosis, although this 
is rare.4
Treatment of mild localised lesions with mupirocin ointment 
is usually adequate. When severe disease with multiple 
lesions is a factor, for example in immunocompromised 
patients, systemic treatment with cloxacillin may be 
necessary.
Carbuncles result when a group of contiguous hair follicles 
become deeply infected with S. aureus. The condition 
is characterised by intense inflammatory changes in 
the surrounding connective tissues, as well as the 
subcutaneous fat. A carbuncle starts as a small painful 
erythematous nodule that is dome-shaped and tender 
to the touch. Inflammatory changes and necrosis of the 
intervening skin may occur. There may be high fever and 
malaise. Carbuncles are treated with cloxacillin or other 
penicillinase-resistant antibiotics. In some cases, incision 
and drainage may be necessary.
Staphylococcal scalded skin syndrome 
Staphylococcal scalded skin syndrome is a generalised, 
confluent, erythematous superficial exfoliation that 
commonly occurs in neonates and young children, 
following infection by certain strains of toxin-producing 
S. aureus. It is rare in adults. Predisposing factors include 
immunosuppression, renal failure and malignancy.
Outbreaks in nurseries have been reported.11 The 
staphylococcal infection usually originates at a distant 
focus, like the pharynx or nose. Septicaemia or cutaneous 
Figure 5: Cellulitis on the cheek.
Figure 6: Furunculosis in an elderly diabetic patient
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infection may also be the cause. Other primary infection 
foci from the urinary tract, umbilicus and conjuctivae can 
also lead to staphylococcal scalded skin syndrome. The 
associated strain of staphylococcus releases exfoliatin, an 
epidermolytic toxin that causes skin desquamation. The 
disease starts abruptly with fever, skin tenderness and 
erythema, sparing palms, soles and mucous membranes. 
This differentiates it from toxic epidermal necrolysis, 
which is drug-induced. The erythema in staphylococcal 
scalded skin syndrome is often accentuated in flexural and 
periorificial areas. 
Generalised exfoliation follows within a few hours or 
days, leaving raw, painful areas. Pus swabs from the 
skin lesions usually yield staphylococci. This is because 
the desquamation is mediated by toxins which are 
disseminated haematogenously. The same toxins are 
present in bullous impetigo which may be regarded as a 
localised form of staphylococcal scalded skin syndrome. If 
it can be identified, the staphylococci can be isolated from 
the original infection site.
Early administration of intravenous antibiotics, such as 
cloxacillin or a cephalosporin, results in a good recovery 
within seven to ten days. Intravenous penicillinase-
resistant, anti-staphylococcal antibiotics, supportive skin 
care, as well as fluid and electrolyte management in the 
setting of disrupted skin barrier function, will ensure rapid 
recovery.² In children, where there is usually no underlying 
predisposing factor, the prognosis is good.12,13
Staphylococcal scalded skin syndrome epidemics in 
neonatal nurseries can occur. Typically, the source of such 
outbreaks are nursery or maternity staff infected with, 
or colonised by epidermolytic toxin-producing S. aureus. 
Identification of health care workers who are colonised 
by, or infected with toxigenic strains of S. aureus, is an 
integral part of managing these outbreaks. Infection control 
measures, including strict enforcement of chlorhexidine 
hand washing, oral antibiotic therapy for infected health 
care workers, and the application of mupirocin nasal 
ointment for the eradication of persistent nasal carriage, are 
usually adequate.12,14
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